The WACC of Laurus Labs Ltd (LAURUSLABS.NS) is 14.0%.
Range | Selected | |
Cost of equity | 13.30% - 15.70% | 14.50% |
Tax rate | 25.80% - 27.40% | 26.60% |
Cost of debt | 9.10% - 9.40% | 9.25% |
WACC | 12.8% - 15.1% | 14.0% |
Category | Low | High |
Long-term bond rate | 6.9% | 7.4% |
Equity market risk premium | 8.3% | 9.3% |
Adjusted beta | 0.78 | 0.85 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 13.30% | 15.70% |
Tax rate | 25.80% | 27.40% |
Debt/Equity ratio | 0.08 | 0.08 |
Cost of debt | 9.10% | 9.40% |
After-tax WACC | 12.8% | 15.1% |
Selected WACC | 14.0% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for LAURUSLABS.NS:
cost_of_equity (14.50%) = risk_free_rate (7.15%) + equity_risk_premium (8.80%) * adjusted_beta (0.78) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.